Suppr超能文献

调节性树突状细胞通过 IFN-β 和 CD40L 使 B 细胞分化为 CD19hiFcγIIbhi 调节性 B 细胞。

Regulatory dendritic cells program B cells to differentiate into CD19hiFcγIIbhi regulatory B cells through IFN-β and CD40L.

机构信息

National Key Laboratory of Medical Immunology and Institute of Immunology, Second Military Medical University, 800 Xiangyin Road, Shanghai, China.

出版信息

Blood. 2012 Jul 19;120(3):581-91. doi: 10.1182/blood-2011-08-377242. Epub 2012 Jun 12.

Abstract

Regulatory dendritic cells (DCs) play important roles in the induction of peripheral tolerance and control of adaptive immune response. Our previous studies demonstrate that splenic stroma can drive mature DCs to proliferate and further differentiate into a unique subset of CD11b(hi)Ia(low) regulatory DCs, which could inhibit T-cell response, program generation of immunosuppressive memory CD4 T cells. However, the effect of regulatory DCs on B-cell function remains unclear. Here, we report that regulatory DCs can induce splenic B cells to differentiate into a distinct subtype of IL-10-producing regulatory B cells with unique phenotype CD19(hi)FcγIIb(hi). CD19(hi)FcγIIb(hi) B cells inhibit CD4 T-cell response via IL-10. CD19(hi)FcγIIb(hi) B cells have enhanced phagocytic capacity compared with conventional CD19(+) B cells, and FcγRIIb mediates the uptake of immune complex by CD19(hi)FcγIIb(hi) B cells. We found that regulatory DC-derived IFN-β and CD40 ligand are responsible for the differentiation of CD19(hi)FcγIIb(hi) B cells. Furthermore, an in vivo counterpart of CD19(hi)FcγIIb(hi) B cells in the spleen and lymph nodes with similar phenotype and regulatory function has been identified. Our results demonstrate a new manner for regulatory DCs to down-regulate immune response by, at least partially, programming B cells into regulatory B cells.

摘要

调节性树突状细胞(DCs)在诱导外周耐受和控制适应性免疫反应中发挥重要作用。我们之前的研究表明,脾脏基质可以驱动成熟的 DC 增殖,并进一步分化为独特的 CD11b(hi)Ia(low)调节性 DC 亚群,其可抑制 T 细胞反应,编程产生免疫抑制性记忆 CD4 T 细胞。然而,调节性 DCs 对 B 细胞功能的影响尚不清楚。在这里,我们报告调节性 DCs 可以诱导脾脏 B 细胞分化为具有独特表型 CD19(hi)FcγIIb(hi)的独特的 IL-10 产生调节性 B 细胞亚群。CD19(hi)FcγIIb(hi) B 细胞通过 IL-10 抑制 CD4 T 细胞反应。与常规 CD19(+) B 细胞相比,CD19(hi)FcγIIb(hi) B 细胞具有增强的吞噬能力,FcγRIIb 介导 CD19(hi)FcγIIb(hi) B 细胞摄取免疫复合物。我们发现调节性 DC 衍生的 IFN-β 和 CD40 配体负责 CD19(hi)FcγIIb(hi) B 细胞的分化。此外,在脾脏和淋巴结中已经鉴定出与 CD19(hi)FcγIIb(hi) B 细胞具有相似表型和调节功能的体内对应物。我们的结果表明,调节性 DCs 通过将 B 细胞编程为调节性 B 细胞来下调免疫反应的一种新方式。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验